Texas Instruments Crushes Q3 2026 Estimates With 77% Earnings Surge, But Stock Barely Moves

By TrendSpider Editor

Texas Instruments delivered a powerful Q3 2026 earnings beat after the close today, reporting earnings per share of $2.62 against a consensus estimate of $2.42, an 8.26% positive surprise, while revenue of $6.055 billion topped expectations of approximately $5.928 billion by 2.14%. Despite the stron

Texas Instruments Crushes Q3 2026 Estimates With 77% Earnings Surge, But Stock Barely Moves

Texas Instruments delivered a powerful Q3 2026 earnings beat after the close today, reporting earnings per share of $2.62 against a consensus estimate of $2.42, an 8.26% positive surprise, while revenue of $6.055 billion topped expectations of approximately $5.928 billion by 2.14%. Despite the strong results, TXN shares moved just -0.05% in postmarket trading, sitting at $279.36 against a 52-week range of $152.76 to $334.03, suggesting the market may have already priced in much of the upside heading into the print.

Key Drivers of the TXN Stock Move

• Main Catalyst: Texas Instruments posted Q3 2026 EPS of $2.62, beating the $2.42 estimate by $0.20, while revenue of $6.055 billion cleared the $5.928 billion bar. Earnings grew 77.03% year over year and revenue climbed 27.69%, marking a substantial acceleration in the company's business momentum.
• Bull Case: A 77.03% surge in earnings and 27.69% revenue growth signal a strong cyclical recovery in the analog and embedded semiconductor market. With EPS coming in 8.26% above estimates and revenue beating by $126.7 million, the fundamental trajectory supports continued upside from the current price of $279.36, which still sits well below the 52-week high of $334.03.
• Bear Case: The near-flat postmarket reaction (-0.05%) despite a blowout quarter raises questions about whether forward guidance or margins disappointed investors. TXN's current price of $279.36 is already elevated relative to the 52-week low of $152.76, and the muted price response may indicate that the strong results were largely anticipated, leaving less room for a meaningful re-rating higher in the near term.

The forward setup for Texas Instruments looks constructive on the surface given the magnitude of the earnings and revenue beats. A 77% year-over-year earnings increase is not a routine outperformance, it reflects a company benefiting meaningfully from the ongoing restocking cycle in the semiconductor industry and robust end-market demand, particularly from industrial and automotive customers, which are TXN's two largest revenue segments. That said, the market's lukewarm postmarket response is worth monitoring closely. Investors will be listening carefully to management's commentary on inventory levels, customer order patterns, and capital expenditure plans, as TXN has been investing heavily in domestic manufacturing capacity. Any softness in the forward outlook or guidance range could quickly reverse the positive earnings momentum. With the stock sitting roughly 16% below its 52-week high of $334.03, there is room to run if the tone on the call is constructive, but the lack of an immediate pop suggests traders are waiting for confirmation before committing further.

TXN Seasonality

Texas Instruments typically reports Q3 results in late October, a period that has historically aligned with a seasonal upturn in semiconductor demand heading into year-end. Strong Q3 beats in prior cycles have often set a positive tone for the stock into the fourth quarter, though the degree of follow-through has varied depending on the macro environment and forward guidance.

TXN Relative Performance

TXN's current price of $279.36 places it in the upper half of its 52-week range of $152.76 to $334.03, reflecting a significant recovery from its annual lows. The muted postmarket move of -0.05% following a strong earnings beat contrasts with how other large-cap semiconductor names have responded to similar beats this cycle, suggesting that sector rotation or broader market caution may be weighing on the stock's immediate price discovery relative to its peers.